Bristol-Myers Squibb (BMY) – Large-Cap Pharma Dividend Growth
March 31, 2021 at 11:31 AM EDT
BMY is a global biopharmaceutical company that just took on a compelling investment by acquiring Celgene, which will drive future growth.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |